We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-15.72%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$4.46B
AUM Growth
-$6B
Cap. Flow
-$4.51B
Cap. Flow %
-101.07%
Top 10 Hldgs %
21.21%
Holding
7,134
New
733
Increased
2,939
Reduced
2,324
Closed
739

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$41.1M
2
IWD icon
iShares Russell 1000 Value ETF
IWD
+$25.3M
3
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$18.4M
4
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$15.7M
5
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$15.4M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$411M
2
MSFT icon
Microsoft
MSFT
+$372M
3
AMZN icon
Amazon
AMZN
+$192M
4
TSLA icon
Tesla
TSLA
+$121M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$111M

Sector Composition

Rank Sector Weight
1 Technology 22.54%
2 Healthcare 10.8%
3 Consumer Discretionary 9.19%
4 Financials 8.28%
5 Communication Services 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HTT
4476
High Templar Tech Ltd
HTT
$391M
$10K ﹤0.01%
9,172
-8,510
-48% -$8.3K
REMX icon
4477
VanEck Rare Earth/Strategic Metals ETF
REMX
$2.23B
$10K ﹤0.01%
+117
New +$11.5K
RSI icon
4478
Rush Street Interactive
RSI
$2.85B
$10K ﹤0.01%
2,163
-1,958
-48% -$11.7K
RWAY icon
4479
Runway Growth Finance
RWAY
$292M
$10K ﹤0.01%
+896
New +$11.9K
SGC icon
4480
Superior Group of Companies
SGC
$213M
$10K ﹤0.01%
557
-7,944
-93% -$137K
SLNG icon
4481
Stabilis Solutions
SLNG
$102M
$10K ﹤0.01%
2,393
+1,342
+128% +$6.32K
FTH
4482
Faeth Therapeutics
FTH
$759M
$10K ﹤0.01%
219
-19
-8% -$712
SRG
4483
Seritage Growth Properties
SRG
$131M
$10K ﹤0.01%
1,954
+591
+43% +$5.27K
STXS icon
4484
Stereotaxis
STXS
$137M
$10K ﹤0.01%
5,280
+2,965
+128% +$7.09K
TCRT icon
4485
Alaunos Therapeutics
TCRT
$4.88M
$10K ﹤0.01%
51
-63
-55% -$6.02K
VBIO
4486
Valion Bio
VBIO
$709K
$10K ﹤0.01%
3
+1
+50% +$2.93K
TNGX icon
4487
Tango Therapeutics
TNGX
$4.31B
$10K ﹤0.01%
2,212
+2,112
+2,112% +$12.8K
TOMZ icon
4488
TOMI Environmental Solutions
TOMZ
$12.9M
$10K ﹤0.01%
4,635
+3,841
+484% +$9.4K
UBX
4489
DELISTED
Unity Biotechnology
UBX
$10K ﹤0.01%
1,694
+1,560
+1,164% +$13K
UHG
4490
DELISTED
United Homes Group
UHG
$10K ﹤0.01%
987
-13
-1% -$128
VALU icon
4491
Value Line
VALU
$360M
$10K ﹤0.01%
152
-156
-51% -$10.7K
VIVK
4492
Vivakor
VIVK
$937K
$10K ﹤0.01%
+1
New +$7.73K
VXX icon
4493
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$142M
$10K ﹤0.01%
28
-123
-81% -$48.6K
WEAV icon
4494
Weave Communications
WEAV
$426M
$10K ﹤0.01%
3,314
+1,617
+95% +$7.78K
ZVIA icon
4495
Zevia
ZVIA
$101M
$10K ﹤0.01%
3,524
+1,474
+72% +$4.57K
TECX
4496
Tectonic Therapeutic
TECX
$720M
$10K ﹤0.01%
866
-273
-24% -$3.22K
JCTC
4497
Jewett-Cameron Trading
JCTC
$10.3M
$10K ﹤0.01%
1,645
-2,380
-59% -$16.5K
GDST
4498
DELISTED
Goldenstone Acquisition Limited Common Stock
GDST
$10K ﹤0.01%
+1,000
New +$9.91K
ENLC
4499
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$10K ﹤0.01%
1,235
-38,731
-97% -$389K
SMAR
4500
DELISTED
Smartsheet Inc.
SMAR
$10K ﹤0.01%
341
-7,876
-96% -$326K
178 179
180
181 182

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2022 Portfolio in Review

As of Q2 2022, Tower Research Capital (TRC) held 7,134 positions worth $4.46B, down 57% from $10.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.51B in Q2 2022, closing 739 positions and reducing 2,324 holdings. Its most notable exit was iShares MSCI USA Value Factor ETF, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $23.4M.

  • Tower Research Capital (TRC)'s largest Q2 2022 buy was iShares Russell 1000 Value ETF: 161,690 shares worth $23.4M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q2 2022, an estimated $41.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2022 reduction was Apple, cutting an estimated $411M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Value Factor ETF in Q2 2022, selling an estimated $13.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 21% of its $4.46B portfolio in Q2 2022.
  • Tower Research Capital (TRC) opened 733 new positions and closed 739 in Q2 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 57% quarter-over-quarter to $4.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.